Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-090744
Filing Date
2021-07-09
Accepted
2021-07-09 18:27:57
Documents
1
Period of Report
2021-07-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2121908-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2121908-4_4seq1.xml 4 4021
  Complete submission text file 0001104659-21-090744.txt   5450
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Issuer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address
McCarthy Reid (Reporting) CIK: 0001857733 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39202 | Film No.: 211083871